Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 7 Breast Neoplasms 5 Radiation Fibrosis Syndrome 3 Pancreatic Adenocarcinoma 2 Lung Neoplasms 2 Glioblastoma 2 Thrombocytosis 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Peripheral Nervous System Diseases 1 Pancreatic Ductal Adenocarcinoma 1 Osteosarcoma 1 Neuroma, Acoustic 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Temozolomide 162 Radiosurgery 115 Radiotherapy 100 Bevacizumab 96 Magnetic Resonance Spectroscopy 65 Carboplatin 48 Etoposide 34 pembrolizumab 33 Surgical Procedures, Operative 33 Irinotecan 33 Nivolumab 32 Cyclophosphamide 32 Erlotinib Hydrochloride 31 Radiation 30 Carmustine 28 Cisplatin 25 Lomustine 24 Trastuzumab 23 Ipilimumab 23 Filgrastim 23 Vincristine 20 Mental Status and Dementia Tests 20 Aminolevulinic Acid 19 Topotecan 18 Pemetrexed 18 Capecitabine 18 Specimen Handling 17 Sorafenib 15 Radiotherapy, Intensity-Modulated 15 Imatinib Mesylate 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × Losartan × Clear all

NCT03951142 2023-11-01

ImPRESS

Oslo University Hospital

Phase 2 Unknown

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡